The U.S. Food and Drug Administration (FDA) last week gave emergency use authorization to a new rapid at-home antigen test.
Individuals who show COVID-19 symptoms in the first five days can use this at-home kit to simply collect nasal swab samples and get results within 20 minutes.
“On March 16, the FDA issued an emergency use authorization (EUA) for PHASE Scientific International, Ltd.’s INDICAID COVID-19 Rapid Antigen At-Home Test, an OTC #COVID19 antigen diagnostic. The FDA is committed to increasing the availability of appropriately accurate and reliable at-home COVID19 diagnostic tests, and to facilitate consumer access to these tests,” the FDA said. The details of the approval are laid out in a letter to PHASE Scientific International.
